Meeting
2018 Gastrointestinal Cancers Symposium
The role of stereotactic body radiation therapy using the CyberKnife system in limited hepatic metastases.
Authors
Eman ElAlfy
Alexandria University, Alexandria, Egypt
Eman ElAlfy , Jerome Doyen , Pierre-Yves Bondiau
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 481)
DOI
10.1200/JCO.2018.36.4_suppl.481
Abstract #
481
Poster Bd #
N5
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring for liver tumors using a gimbal-mounted linac: A multi-institutional phase II study.
First Author: Yusuke Iizuka
Poster
2019 Gastrointestinal Cancers Symposium
Local control following stereotactic body radiotherapy to adrenal oligometastases.
First Author: Nicholas B Figura
Poster
2016 Gastrointestinal Cancers Symposium
Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors.
First Author: Alexander V. Kirichenko
Poster
2014 ASCO Annual Meeting
Hepatic oligometastases treated with stereotactic body radiation therapy: Updated 10-year analysis of the Indiana University experience.
First Author: Ben Goodman